1. Introduction {#sec1}
===============

Non-Tuberculous Mycobacteria (NTM) are environmental saprophytes widely distributed in water and soil \[[@B1]\]. They are the genetic progenitors of*M. Tuberculosis*Complex (MTBC), after a series of gene deletions and gene acquisitions \[[@B2]\] with MTBC evolving to a more virulent pathogen. NTM rarely cause disease except when immune function is impaired \[[@B3]\], elderly patients and chronic lung disease. However, some NTM are pathogenic, and recently there has been a reported increase in NTM lymphadenitis \[[@B4], [@B5]\] and Buruli ulcers \[[@B6], [@B7]\].

The shared ancestry of NTM and MTBC is responsible for immune interference in BCG vaccination, via cross reactive immune responses \[[@B2]\]. This could be one of the reasons for low BCG efficacy where NTM are prevalent \[[@B2]\]. Absence of NTM sensitization was associated with higher efficacy of BCG against pulmonary and severe forms of tuberculosis in a systematic review \[[@B8]\]. Surprisingly, the discontinuation of universal BCG vaccination in these countries has seen an increase of NTM lymphadenitis in children, suggesting BCG was also protecting against NTM in that setting \[[@B4]\]. NTM appear to be immune modulators influencing host interactions in BCG efficacy, TB burden, and NTM disease.

The antigen homologues \[[@B2]\] further decrease accuracy of biomarkers distinguishing latent TB infection (LTBI) and NTM exposure.

Pulmonary NTM disease is clinically and radiologically identical to TB and is so diagnosed, in the absence of microbiological confirmation in high TB burden settings. It is a relevant distinction to make as almost all NTM do not respond to anti-tuberculous therapy \[[@B9]\]. Isolation of NTM in sputum is not necessarily disease \[[@B9]\]. Data on NTM disease and prevalent subtypes is limited particularly in countries with a high TB burden. Most studies report on adults \[[@B10]--[@B12]\]. Few studies on NTM in children have been published on the continent \[[@B13]--[@B15]\]. Most document the proportion of NTM among those with presumptive TB. There is also a dearth of knowledge on risk and exposure factors. As infants are the target age group for TB vaccines in the pipeline, it is useful to describe the epidemiological landscape of NTM, given their role in tuberculosis incidence and possibly vaccine efficacy.

The objective of this study was to document the incidence and diversity of NTM disease or colonisation in sputum specimens from infants with presumptive TB, the risk factors, and clinical characteristics, in a high TB and HIV burden setting.

2. Study Population and Methods {#sec2}
===============================

The study took place in Siaya, Western Kenya, a predominantly rural community north of Lake Victoria. The area has a high prevalence of HIV, TB, and malaria. Most women delivered at home \[[@B16]\]. The NTM substudy was part of a prospective cohort study to document the incidence of TB ahead of TB vaccine trials in the same population. Presumably, infants are born uninfected; we present the incidence of NTM in this cohort.

Briefly, parents or guardians of 2900 infants aged zero to six weeks gave written permission for enrollment of their newborns between June 2009 and June 2010. Patients were followed up for at least one year and a maximum of two years. Through four monthly scheduled visits and ancillary care visits, infants were identified as having presumptive TB if they had history of TB contact, symptoms, or signs of pulmonary TB (failure to thrive, cough or night sweats or fever for more than two weeks, a history of hospitalization for HIV/AIDS related illness, lower respiratory tract infections, meningitis, or TB). Consequently, they were admitted into a case verification ward for three days. Two fasted sputum induction specimens and two gastric aspirates were collected on subsequent mornings. Tuberculin Skin Testing (TST) was done with two Tuberculin Units (2TU) from Statens Serum Institut (SSI). TST readings of 10mm and more or 5mm or more among HIV infected children were considered to be positive readings. Further, DNA PCR HIV (COBAS® HIV-1 Amplicor by ROCHE) tests and digital chest radiography were performed.

Patients received anti-tuberculous therapy if they had microbiological confirmation (definite TB) or clinically, based on the Keith Edward TB Score (KE Score) Chart of \>7, or \<7 if the chest radiograph was suggestive (probable TB). Mid-Upper Arm Circumference (MUAC) was used to determine nutritional status for children older than 6 months old at time of TB investigations. Weight for Age Z Score was used for those less than 6 months. HIV infected infants were referred for anti-retroviral treatment initiation and care. Patients vital status at last study contact was documented.

Chest radiographs were read systematically and classified as abnormal probable TB, abnormal not TB, or normal \[[@B17]\]. The study was approved by Kenya Medical Research Institute Independent Ethics Committee (KEMRI-IEC) SSC 1465. The data used to support the findings of this study are available from the corresponding author upon request.

We applied the American Thoracic Society\'s \[[@B18]\] criteria to establish clinical significance of positive NTM cultures.

2.1. Laboratory Methods and Sample Decontamination {#sec2.1}
--------------------------------------------------

Induced sputum and gastric aspirates were transported to the laboratory at 2 to 8°C, processed using freshly prepared N-acetyl L-cysteine (NALC)-4% sodium hydroxide (NaOH)-2.9% sodium citrate at a final concentration of 1%. Gastric aspirates with \>5ml volume were concentrated by centrifugation and pellet resuspended with 5ml phosphate buffer saline (PBS). Digestion was stopped using pH 6.8 PBS after 20 minutes. Centrifugation was done at 3,000 x g for 15 minutes at 4°c. Supernatant was discarded and the pellet resuspended with 2ml PBS. This was used for inoculation of Lowenstein Jensen (LJ) \[BD\] media (0,2ml), fluorescent microscopy, and mycobacteria growth indicator tube (MGIT) \[BD\] (0.5ml). LJ were incubated in 37°C CO~2~ incubators for 8 weeks, and MGIT was incubated in automated BACTEC ™ MGIT ™ 960 \[BD\] for 42 days. Artificial sputum was used as a negative control sample to check for cross-contamination with each batch processed.

MGIT cultures that turned positive were stained for acid fast bacilli (AFB) using Ziehl Neelsen (ZN). Contamination was checked by inoculation and incubation of blood agar plates at 37°c and read after 48 hours. Samples that tested ZN negative but Blood Agar Plate (BAP) positive ≥7 days later were discarded as contaminated. Those \<7 days were redigested using 4% NaOH as described in MGIT™ procedure manual \[[@B19]\]. AFB positive cultures were tested by immunochromatographic assay (ICA) such as Capilia™ TB-Neo (TAUNS Laboratories, Numazu, Japan) or BD MGIT™ TBc identification kit ((BD, Franklin Lakes, NJ, USA) to identify whether NTM or MTBC.

For LJ cultures with visible growth, we assessed colony morphology. Those suggestive of mycobacteria were identified using ZN smear, and those AFB positive were tested with ICA.

NTM culture isolates were genetically identified to the species level using Genotype Mycobacterium Common Mycobacterium (CM) or Additional Species (AS) kits (HAIN Lifescience, Nehren, Germany). The procedure was done according to manufacturer\'s instructions.

2.2. Statistical Methods {#sec2.2}
------------------------

Frequency methods were used to describe the baseline characteristics. Odds ratios were used to analyze whether differences between those with and without NTM were due to chance. T-tests were used to compare the mean age at TB investigations. To evaluate differences in clinical characteristics, known and potential risk factors, logistic regression was performed. NTM cases that had microbiologically confirmed or clinical TB were analysed as TB cases. A-priori risk factors included infant and maternal HIV infection, nutritional status, housing, and number of siblings.

3. Results {#sec3}
==========

Of 2900 infants enrolled, 927 (32%) were suspected to have TB (presumptive TB) during their 1-2-year follow-up. Of these 742 (80%) were admitted for investigations ([Figure 1](#fig1){ref-type="fig"}). There were 19 NTM identified following culture (2.6% of 742). Total person-time of follow-up was 3330.3 years. The incidence of NTM was 5.7 per 1,000 person-years (pyo) of follow-up (95% CI 3.5, 8.7), while all TB incidence (49 cases) was 15/1000 pyo (95% CI, 11-20) and microbiologically confirmed TB incidence was 2.7/1,000 pyo. At baseline, there were no statistically significant differences between those who had NTM identified versus all other infants ([Table 1](#tab1){ref-type="table"}).

Upon bivariate comparison of clinical characteristics between presumptive TB patients and NTM cases, there were no statistically significant differences ([Table 2(a)](#tab2){ref-type="table"}). However, odds of a positive NTM among infants with TB was eleven-fold that of infants with no TB (OR 11.6 (95% CI 3.25, 41.0). NTM cases had forty-eight-fold higher odds of having microbiologically confirmed TB compared to all presumptive TB (OR 48.3 95% CI 9.3, 249) ([Table 2(a)](#tab2){ref-type="table"}).

There were no differences between NTM cases and other presumptive TB cases in mean age at time of TB investigations ([Table 2(b)](#tab2){ref-type="table"}).

[Table 3](#tab3){ref-type="table"} shows the NTM identified and the individual\'s clinical characteristics.*M. fortuitum* (6/19 32%) and*M. scrofulaceum* (2/19 11%) were most frequently isolated. Two of the 19 (11%) were unidentifiable. Two patients had MTBC and NTM coinfection.

Applying the ATS criteria for diagnosis of NTM disease, none of the NTM cases qualified as having NTM disease. Only 1/19 (5.3%) NTM case was HIV infected which had NTM cultured (*M. asiaticum*) while 3/19 (16%) were born to mothers who tested HIV positive but were themselves uninfected (HUE).

In our study, rapidly growing mycobacteria (RGM), which form colonies in less than seven days, were isolated most frequently (10/19) ([Table 3](#tab3){ref-type="table"}). The most frequently isolated NTM in pediatric studies are shown in [Table 4](#tab4){ref-type="table"}.*M. fortuitum* was the most frequently isolated NTM among the identified studies.

4. Discussion {#sec4}
=============

4.1. Burden of NTM {#sec4.1}
------------------

The proportion of NTM in pulmonary samples of presumptive TB cases in this infant cohort was relatively low (2.6%; 95% CI 1.5, 3.8). Standard sputum decontamination procedures were judiciously applied; hence it is unlikely that NTM yield was affected by this. A similar study among infants in Uganda and South Africa found 3.7% \[[@B14]\] and 6% \[[@B13]\], respectively. The epidemiology of exposure in this region could be nonlinear, where exposure in early childhood is minimal but increases rapidly in adolescents. A significantly higher proportion of NTM were identified among presumptive TB cases in adolescents in the study area (37.5%), at the time of the study (V. Nduba, Personal Communication). Nevertheless, the Mozambique cohort and a survey in Ethiopia had more NTM \[[@B15], [@B20]\], and the average prevalence in African adult pulmonary samples was 7.5% in a systematic review \[[@B10]\]. It is possible that BCG is protective against NTM colonisation. A twenty-year retrospective study of NTM notifications in children demonstrated increased odds of NTM disease when universal BCG vaccination was halted in Finland \[[@B4]\]. Therefore, BCG could also protect against colonisation. This can be evaluated conclusively in head to head comparisons of BCG and recombinant BCG vaccines presently in phase III clinical trials \[[@B21]\].

4.2. Colonisation or NTM Disease/Clinical Relevance {#sec4.2}
---------------------------------------------------

We did not find statistically significant differences in baseline characteristics between NTM cases and other presumptive TB patients suggesting widespread exposure across the study population. There were no differences in the clinical or radiological characteristics between presumptive TB and NTM cases.

NTM disease is clinically and radiologically indistinguishable from TB \[[@B9]\]. Two NTM cases were symptomatic with a suggestive radiological picture and would have qualified as NTM disease, but MTBC was also isolated from their sputum. The remainder had no combination of suggestive clinical or radiological features. We therefore conclude the NTM cases represent colonization. There is a possibility that these are laboratory contaminants; however this is unlikely since we checked for contaminants by having negative controls.

4.3. Risk Factors {#sec4.3}
-----------------

### 4.3.1. Environmental Exposure {#sec4.3.1}

We did not identify any environmental risk factors for NTM incidence. Unlike MTBC which is transmitted from person to person, NTM transmission occurs via repeated environmental exposure. In infants, this would be through handling by parents and siblings. The study area is rural. Risk for acquiring NTM is significantly higher in communities engaged in occupations that generate aerosols and are exposed to soil for prolonged periods such as agriculture \[[@B22]\]. It is not clear what the environmental source of these NTM is.

4.4. Host Factors {#sec4.4}
-----------------

Host factors predisposing to NTM isolation were intercurrent MTBC disease and severe undernutrition, although the latter did not reach statistical significance. Past history of TB has been known to be a risk factor for NTM disease \[[@B23], [@B24]\], since we studied infants that could not be confirmed. Interestingly, in this study, MTBC isolation increased the odds of NTM isolation almost fifty-fold. NTM-MTBC coinfection in the same infant host has been observed \[[@B13], [@B15]\], and in adults in high TB burden countries \[[@B25]\]. TB appears to be a preexisting lung condition predisposing to NTM colonisation \[[@B9]\].

Low Body Mass Index and poor nutrition are other possible host factors, even predicting risk of disseminated NTM disease in other studies \[[@B26], [@B27]\], our study seemed to show the same trend.

Only in one case was the NTM case HIV infected, indicating among infants in this region, immunodeficiency is not a factor in NTM isolation in sputum.

4.5. NTM Isolated {#sec4.5}
-----------------

The spectrum of organisms identified in this NTM study is similar in type and frequency to those reported in Uganda \[[@B14]\], Ethiopia \[[@B20]\], and Saudi Arabia \[[@B24]\].*M. fortuitum* was most frequently isolated in these studies. There could be geographic and climatic factors in the distribution. All the regions have warm climates. Increase in latitude and polarity has been shown to be associated with higher isolation rates of more pathogenic, slow growing mycobacteria \[[@B4], [@B13], [@B15]\].

4.6. TB Diagnostics {#sec4.6}
-------------------

There was no detectable difference in TST positivity between NTM cases and other patients whereas NTM sensitization is known to be responsible for false positive TST readings. Indeed false positive TSTs due to NTM are infrequent and mainly relevant in areas with low TB endemicity \[[@B28]\].

4.7. BCG Efficacy {#sec4.7}
-----------------

NTM influence the relative efficacy of BCG vaccines \[[@B29]\]. The nature and type of NTM isolated in TB endemic countries are critical to an efficient vaccination campaign \[[@B2]\]. The relative frequency of isolated species may correlate with the prevalence of skin sensitivity to their antigens, as was shown in Malawi \[[@B11]\]. RGMs have been shown to be protective against leprosy and TB \[[@B11]\]. This could not be confirmed in the current study due to the low numbers of NTM isolated.

As there was no unvaccinated control group, it is not possible to assess efficacy of BCG. Thus, it appears that the risk of exposure to NTM as a covariate of vaccine efficacy, as has been previously suggested, is quite low in the target age group.

4.8. Limitations {#sec4.8}
----------------

Our analysis was limited due to the small proportion of NTM isolated in this age group. Nevertheless, it forms a baseline assessment for future studies including future vaccine trials.

Also, not all infants could be tested for NTM; this was not the primary objective, and it is challenging to obtain samples from children without presumptive TB. Therefore, the NTM incidence may be an underestimate of the NTM burden in the population.

5. Conclusions {#sec5}
==============

This study has attempted to document the incidence of NTM among infants thought to have TB. The clinical relevance of NTM isolated points to colonisation and not disease, as all the infants from whom NTM were isolated did not meet the ATS criteria for disease. Our data shows that a patient presenting with features of TB is less likely to have NTM disease, in similar settings.
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###### 

Baseline characteristics of study sample, infants with presumptive TB and infants with NTM isolated; and comparison between infants with presumptive TB with and without NTM.

  ------------------------------------------------------------------------------------------------------------------------
  Characteristic                    Study Sample\   Investigated for Presumptive TB\   NTM positive\   OR (95%CI) *∗*
                                    (n=2900)        (n =742)\                          (n=19)\         
                                                    (N, column %)                      (N, row%)       
  --------------------------------- --------------- ---------------------------------- --------------- -------------------
  *Gender*                                                                                              

  Female                            1412            358 (48%)                          10 (2.8%)       1 (ref)

  Male                              1488            384 (52%)                          9 (2.3%)        0.85 (0.35, 2.11)

                                                                                                       

  *Enrolment weight*                                                                                    

  Normal                            2674            667 (90%)                          16 (2.4%)       1 (ref)

  low                               226             75 (10%)                           3 (4.1%)        2.24 (0.65, 7.73)

                                                                                                       

  *Place of birth*                                                                                      

  Home                              1840            510 (69%)                          11 (2.2%)       0.77 (0.31, 1.93)

  Health facility                   1038            229 (31%)                          8 (3.5%)        1 (ref)

  missing                           22              3 (\<1%)                                            

                                                                                                       

  *Maternal HIV status*                                                                                 

  HIV negative                      2451            598 (81%)                          16 (2.7%)       1 (ref)

  HIV positive                      401             127 (17%)                          3 (2.4%)        0.88 (0.25, 3.08)

  Unknown                           48              17 ( 2%)                                            

                                                                                                       

  *Infant HIV status*                                                                                   

  HIV negative                      2827            708 (95%)                          18 (2.5%)       1 (ref)

  HIV positive                      73              34 (5%)                            1 (2.9%)        2.17 (0.29, 16.5)

                                                                                                       

  *Maternal age category*                                                                               

  \<19                              635             152 (21%)                          1 (0.7%)        1 (ref)

  20-29                             1533            384 (52%)                          16 (4.2%)       6.69 (0.89, 50.5)

  \>29                              732             206 (28%)                          2 (1.0%)        1.74 (0.16, 19.2)

                                                                                                       

  *Maternal Occupation*                                                                                 

  Unemployed                        1676            409 (55%)                          11 (2.7%)       1 (ref)

  Farmer                            864             250 (34%)                          5 (2.0%)        0.88 (0.31, 2.54)

  Business                          260             61 (8%)                            2 (3.3%)        1.17 (0.26, 5.32)

  Salaried                          71              13 (2%)                            1 (7.7%)        2.16 (0.28, 17.0)

  Unknown                           29              9 (1%)                                              

                                                                                                       

  *Housing Type*                                                                                        

  Mud House                         1912            523 (71%)                          11 (2.1%)       1(ref)

  Semi-permanent                    527             125 (17%)                          4 (3.2%)        1.32 (0.42, 4.17)

  Permanent                         426             84 (11%)                           4 (4.8%)        1.64 (0.52, 5.17)

  Other                             6               1 (0.1%)                                            

  Unknown                           29              9 (1.2%)                                            

                                                                                                       

  *Number of Siblings*                                                                                  

  None                              649             129 (17%)                          3 (2.3%)        1 (ref)

  One to three                      1497            391 (53%)                          14 (3.6%)       2.03 (0.58, 7.10)

  \>3                               754             222 (30%)                          2 (0.9%)        0.57 (0.10, 3.44)

                                                                                                       

  *Vaccination Status at 6 weeks*                                                                       

  Complete                          2205            682 (92%)                          16(2.4%)        0.48 (0.11, 2.10)

  Incomplete                        133             29 (4%)                            2(7.0%)         1 (ref)

  Missing                           562             31 (4%)                            1(3.2%)          
  ------------------------------------------------------------------------------------------------------------------------

*∗* Odds of being NTM case among those investigated for presumptive TB, given the category of baseline characteristic.

###### 

\(a\) Comparative clinical characteristics of those investigated for presumptive TB and infants with NTM isolated (categorical).

  Clinical Characteristics                Presumptive TB   NTM +ve     OR (95%CI)
  --------------------------------------- ---------------- ----------- -------------------
  *Any TB case (clinical or confirmed)*                                 
  No                                      694 (94%)        16 (2.3%)   1 (ref)
  Yes                                     48 (6.5%)        3 (6.3%)    11.6 (3.25, 41.0)
                                                                       
  *MTBC +ve TB case*                                                    
  No                                      733 (99%)        17 (2.3%)   1 (ref)
  Yes                                     9 (1%)           2 (22.2%)   48.3 (9.34, 249)
                                                                       
  *Chest Radiograph*                                                    
  Normal                                  590 (80%)        13 (2.2%)   1(ref)
  Abnormal not TB                         110 (15%)        4 (3.6%)    1.71 (0.55, 5.35)
  Abnormal TB                             35 (5.0%)        2 (5.7%)    2.80 (0.61, 12.9)
  missing                                 7 (0.9%)                      
                                                                       
  *Keith Edward TB score*                                               
  \<7                                     675 (90%)        17 (2.5%)   1 (ref)
  \>=7                                    32 (4.3%)        2 (6.3%)    2.62 (0.58, 11.9)
  Missing                                 35 (4.7%)                     
                                                                       
  *Reason for TB suspicion*                                             
  History of hospitalization                                            
  No                                      283 (38%)        8 (3.4%)    1 (ref)
  Yes                                     426 (57%)        11(2.6%)    0.78 (0.31, 1.97)
  Missing                                 33 (5.0%)                     
                                                                       
  *TB Contact History*                                                  
  No                                      579 (78%)        13(2.3%)    1 (ref)
  Yes                                     131 (18%)        6 (4.6%)    2.57 (0.96, 6.88)
  Missing                                 32 (4.0%)                     
                                                                       
  *TST results*                                                         
  Negative                                555 (76%)        14 (74%)    1 (ref)
  Positive                                172 (24%)        5 (26%)     1.15 (0.41, 3.25)
                                                                       
  *TB symptoms*                                                         
  No                                      530 (71%)        15 (2.8%)   1 (ref)
  Yes                                     180 (24%)        4 (2.2%)    0.85 (0.28, 2.58)
  Missing                                 32 (4.0%)                     
                                                                       
  *Nutritional Status at admission*                                     
  Healthy                                 379 (51%)        8 (2.1%)    1 (ref)
  At risk                                 195 (27%)        6 (3.0%)    1.48 (0.51, 4.32)
  Moderate Acute                          113 (15%)        2 (1.8%)    0.84 (0.18, 4.03)
  Malnutrition (MAM)                                                    
  Severe Acute                            40 (5%)          3 (7.5%)    3.73 (0.95, 14.7)
  Malnutrition (SAM)                                                    
  Missing                                 15 (2%)                       

###### 

\(b\) Comparative clinical characteristics for those investigated for presumptive TB and infants with NTM isolated (continuous variable).

  Clinical Characteristic                 Categories                    n     Mean age (95% CI)   Rank sum p- value/t-test p value
  --------------------------------------- ----------------------------- ----- ------------------- ----------------------------------
  Mean age at TB investigation (months)   NTM negative Presumptive TB   718   9.34 (8.95, 9.74)   0.20
                                                                                                  
                                          NTM case                      19    11.0 (8.02, 13.9)    
                                                                                                  
                                          Missing                       5                          

###### 

NTM identified; clinical and radiological profile of cases.

  Number                           Age (months) at admission   NTM species   MTBC +ve              Infant HIV status   Nutritional status at admission   TST reading (mm)   KE Score   Vital Status   CXR     Siblings             Housing   
  -------------------------------- --------------------------- ------------- --------------------- ------------------- --------------------------------- ------------------ ---------- -------------- ------- -------------------- --------- -------
  *Rapidly Growing Mycobacteria*                                                                                                                                                                                                             
                                                                                                                                                                                                                                             
  1                                52452                       14            *M. peregrinum*       No                  Negative                          At risk            0          0              alive   Normal               4         Mud
                                                                                                                                                                                                                                             
  2                                50170                       5             *M. smegmatis*        No                  Negative                          Healthy            4          0              alive   Normal               1         Semi
                                                                                                                                                                                                                                             
  3                                50220                       11            *M. smegmatis*        No                  Negative                          At risk            3          1              alive   Normal               unknown   Semi-
                                                                                                                                                                                                                                             
  4                                51388                       5             *M. chelonae*         No                  Negative                          Healthy            0          0              Alive   Normal               2         mud
                                                                                                                                                                                                                                             
  5                                52696                       5             *M. fortuitum1*       No                  Negative                          Healthy            0          0              Alive   Abnormal not TB      6         mud
                                                                                                                                                                                                                                             
  6                                52727                       13            *M. fortuitum1*       No                  Negative                          SAM                10         6              alive   Normal               3         mud
                                                                                                                                                                                                                                             
  7                                50206                       6             *M. fortuitum1*       No                  Negative                          Healthy            12         3              Alive   Normal               1         stone
                                                                                                                                                                                                                                             
  8                                50523                       22            *M. fortuitum1*       No                  Negative                          At risk            0          0              Alive   Normal               1         stone
                                                                                                                                                                                                                                             
  9                                51104                       19            *M. fortuitum1*       No                  Negative                          Healthy            1          1              Alive   Normal               1         mud
                                                                                                                                                                                                                                             
  10                               52024                       7             *M. fortuitum2*       No                  Negative-HUE                      Healthy            0          1              alive   Normal               1         mud
                                                                                                                                                                                                                                             
  *Slow Growing Mycobacteria*                                                                                                                                                                                                                
                                                                                                                                                                                                                                             
  11                               51599                       9             *M. asiaticum*        Yes                 Positive                          SAM                7          10             Died    Abnormal not TB      unk       stone
                                                                                                                                                                                                                                             
  12                               50049                       4             *M. celatum*          No                  Negative                          MAM                0          0              Alive   Normal               3         mud
                                                                                                                                                                                                                                             
  13                               51598                       7             *M. gordonae*         No                  Negative                          At risk            1          1              alive   Abnormal not TB      3         mud
                                                                                                                                                                                                                                             
  14                               52683                       9             *M. intracellulare*   No                  Negative                          Healthy            0          0              alive   Abnormal not TB      3         Semi-
                                                                                                                                                                                                                                             
  15                               51119                       12            *M. malmoense*        No                  Negative                          At risk            2          1              alive   Normal               2         Semi-
                                                                                                                                                                                                                                             
  16                               50380                       23            *M. scrofulaceum*     No                  Negative-HUE                      At risk            12         4              alive   Abnormal TB likely   3         Mud
                                                                                                                                                                                                                                             
  17                               50108                       20            *M. scrofulaceum*     No                  Negative                          Healthy            3          3              alive   Normal               1         mud
                                                                                                                                                                                                                                             
  *Unidentified Mycobacteria*                                                                                                                                                                                                                
                                                                                                                                                                                                                                             
  18                               50178                       11            Unidentified          No                  Negative-HUE                      Healthy            0          0              alive   Normal               unk       mud
                                                                                                                                                                                                                                             
  19                               51706                       6             Unidentified          Yes                 Negative                          SAM                12         13             alive   Abnormal TB likely   2         stone

###### 

Pediatric NTM studies in Africa between years 2000 and 2018.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors, Country, Year of Publication       Study Type                        Study Population   NTM proportion of Presumptive TB   Most frequently isolated NTM   Clinical Relevance*∗*   MTBC-NTM co-infection   Proportion of participants with TB   National/local TB prevalence per 100,\
                                                                                                                                                                                                                                                          000 at time of study
  ------------------------------------------- --------------------------------- ------------------ ---------------------------------- ------------------------------ ----------------------- ----------------------- ------------------------------------ ----------------------------------------
  Present Study (Kenya)                       Prospective Cohort Study          \<2 years          2.6%                               *M. fortuitum* (32%)           Colonisation            2/19                    1.5%                                 600 \[[@B31]\]

                                                                                                                                                                                                                                                          

  Asiimwe B, Uganda 2013 \[[@B14]\]           Prospective Cohort Study          \<1 year           3.7%                               *M. fortuitum* (64%)           Not specified           0                       Not specified                        193 \[[@B32]\]

                                                                                                                                                                                                                                                          

  Hatherill M, South Africa 2006 \[[@B13]\]   Prospective Cohort Study          \<2 years          6%                                 *M. intracellulare* (41%)      7/109-NTM disease       5/109                   11%                                  960 \[[@B33]\]

                                                                                                                                                                                                                                                          

  Lopez-Varela E, Mozambique\                 Prospective Cohort Study          \<2 years          26%                                *M. intracellulare* (68%)      Colonisation            0                       \>1.4%                               \>544 \[[@B34]\]
  2017 \[[@B15]\]                                                                                                                                                                                                                                         

                                                                                                                                                                                                                                                          

  Workalemahu B,\                             Cross sectional Hospital Survey   \<15 years         9.9%                               *M. fortuitum*(29%)            Not specified           0                       15%                                  237 \[[@B20]\]
  Ethiopia\                                                                                                                                                                                                                                               
  2013 \[[@B20]\]                                                                                                                                                                                                                                         
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*∗*Based on authors\' description of suggestive clinical and radiological features.
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